{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-001914","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2022-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.995209+00:00","generated_at":"2026-06-27T20:16:49.885988+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Elanco EVP Aaron Schacht departs Dec 31 to lead microbiome platform carve-out; service fee up to $750k","bullets":["Aaron Schacht separated from Elanco on Dec 31, 2021 as part of restructuring plan announced Nov 30, 2021.","Schacht will lead external team developing Microbiome Platform; Elanco to pay service fee up to $750k through Mar 31, 2022.","Contingent fee may be paid upon consummation of carve-out transaction.","Severance Agreement provides benefits under Elanco Executive Severance Pay Plan, contingent on release of claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-001914","json":"https://secwatch.observer/filing/0001104659-22-001914.json","markdown":"https://secwatch.observer/filing/0001104659-22-001914.md","text":"https://secwatch.observer/filing/0001104659-22-001914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922001914/0001104659-22-001914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922001914/tm221865d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:16:49.885988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae3055a447","claim":"Aaron Schacht departed as Executive Vice President at Elanco Animal Health Inc.","evidence_excerpt":"On December 31, 2021, Mr. Schacht, and certain other employees supporting the Microbiome Platform, separated from Elanco as part of the restructuring plan announced by Elanco on November 30, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922001914/0001104659-22-001914-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Executive Vice President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}